Bioqube Ventures
Venture capitalBrussels · Seed–Late Stage
Frequently asked questions
- What stage does Bioqube Ventures invest at?
- Bioqube Ventures invests at the Seed, Series A, Series B, Series C, Late Stage stages.
- What is Bioqube Ventures's typical check size?
- Bioqube Ventures typically writes checks of $108K – $6.5M.
- What sectors does Bioqube Ventures focus on?
- Bioqube Ventures focuses on Biotech, Medical Devices.
- Where is Bioqube Ventures located?
- Bioqube Ventures is headquartered in Brussels, BE.
Similar investors
An early-stage venture capital firm focused on investing in Africa-based entrepreneurs building solutions for regional and global markets.
500 Global's Sustainable Growth practice designs and implements sovereign-aligned strategies that unlock resilient, inclusive, and sustainable economic growth across the Global Majority—Asia, Africa, Latin America, and the Middle East. The practice bridges public priorities and private capital through ecosystem development, blended finance, and localized innovation programs addressing health, agriculture, gender, climate, and education.
83North is a lean venture capital partnership of four equal general partners that has operated for 19 years. The firm invests globally across the US, Europe, and Israel, and in 2025 raised what it describes as its final fund, shifting focus toward selectively pursuing new opportunities while supporting existing portfolio companies.
8VC is a technology investment firm focused on building and investing in ambitious companies across life sciences, healthcare, manufacturing, enterprise, logistics, and defense sectors, with particular emphasis on operational intelligence and data-driven decision-making.